Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1791 (LINC01791) is a human long non-coding RNA classified as a lincRNA, meaning it is transcribed from a region that does not overlap any protein-coding gene. LincRNAs are a subclass of long non-coding RNAs (lncRNAs), which are typically longer than 200 nucleotides and do not encode proteins. LincRNAs play important roles in various aspects of gene regulation, including chromatin modification and transcriptional control, although the precise function of LINC01791 itself is not characterized in available functional databases or the scientific literature. There are no documented pharmacological agents, mechanisms of action, or established clinical relevance specifically associated with LINC01791. LincRNAs as a class can function in both cis or trans to regulate gene expression, impact chromatin state, or influence cellular phenotypes, but functions are highly molecule-specific and often uncharacterized for individual lincRNAs. No reports or database entries explicitly indicate that LINC01791 serves as a biomarker, therapeutic target, or has safety/therapeutic relevance at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1791 (LINC01791).